Roberta Diaz Brinton, professor of molecular pharmacology and toxicology at the USC School of Pharmacy, has been named vice provost for institutional diversity.
In announcing the appointment, USC Provost Lloyd Armstrong Jr. said, “I am pleased that Dr. Brinton will be working with me to assist the academic community in incorporating diverse perspectives in curricula, research and campus life.”
USC School of Pharmacy Dean Timothy M. Chan said, “It is an honor for the School of Pharmacy to have a member of the faculty selected for such an important role in the university administration.”
Aside from her faculty position in the School of Pharmacy, Brinton holds a joint appointment in the Department of Biomedical Engineering and is a founding member of the USC Neuroscience Program.
For the past 15 years, she also has directed the Science, Technology and Research (STAR) program, which provides junior and senior high school students in Los Angeles with the opportunity to join a USC basic science research team for one or more years as part of their high school curriculum.
The STAR program is now part of the larger Biomimetic MicroElectronic Systems Engineering Research Center, which is funded by a $17-million grant from the National Science Foundation.
The center will support educational programs designed to help local students at all levels of schooling to prepare for careers in research and will work with local colleges to develop programs preparing students for careers in the high-tech biotechnology industry. Brinton is director of the education and outreach component of the center.
Brinton earned her doctorate in psychobiology and neuropharmacology from the University of Arizona as a National Institutes of Health (NIH )predoctoral fellow. She continued her postdoctoral training in neuroendocrinology at Rockefeller University as an NIH fellow and joined USC in 1988.
Brinton has published numerous scientific works, received the USC Remarkable Woman Award in 2003 and was selected as one of the 10 Best Minds for 2004 by U.S. News & World Report.